Bridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Conversations in CV Risk AssessmentBridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Jennifer Caudle, DO, FACOFP
Dustin Le, MD, MHS
Niloo Nobakht, MD, FASN
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Heart MattersEarly Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Valmiki Maharaj, MD
Ronald Witteles, MD
Nutritional Strategies for Inflammatory Balance and Immune Readiness
NutritionEdgeNutritional Strategies for Inflammatory Balance and Immune Readiness
Steve Jackson, PharmD
Cassie Smith, MD
Maria Gkini, MD, MSc, PhD
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
On the Frontlines of ATTR-CMEarly Detection of ATTR-CM: Clinical Clues and Imaging Approaches
Shelina Ramnarine, PhD
Valmiki Maharaj, MD
- advertisement
From Prevalence to Practice: Practical Screening and Workup for Hypercortisolism in Resistant Hypertension
CME/CEFrom Prevalence to Practice: Practical Screening and Workup for Hypercortisolism in Resistant Hypertension
Jorge Plutzky, MD
Bradley Eilerman, MD, MHI
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
CME/CEReimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
Alireza Atri, MD, PhD
Raymond Scott Turner, MD, PhD
Dani Cabral, MD
The Cortisol Clue: Diagnosing Hypercortisolism in People with Difficult-to-Control Cardiometabolic Conditions
CME/CEThe Cortisol Clue: Diagnosing Hypercortisolism in People with Difficult-to-Control Cardiometabolic Conditions
Hanford Yau, MD, CCD, FACP, FACE
Eden Miller, DO, D-ACD, D-ABOM
Continuing the Search: New Data on Hypercortisolism Prevalence in Difficult-to-Control Metabolic Conditions
CME/CEContinuing the Search: New Data on Hypercortisolism Prevalence in Difficult-to-Control Metabolic Conditions
Christian Mende, MD, FACP, FACN, FASN, FASH, FAHA
Deepak Bhatt, MD, MPH, MBA, FACC, FAHA
DKA in the Real World: Evidence and Cases that Matter
CME/CEDKA in the Real World: Evidence and Cases that Matter
Carol Wysham, MD
Samuel Seidu, MD, FRCP(Edin), FRCGP
Leveraging CGM to Its Full Potential in People with T2D
CME/CELeveraging CGM to Its Full Potential in People with T2D
John E. Anderson, MD
Davida F. Kruger, CNP
- advertisement
Bridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Conversations in CV Risk AssessmentBridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Jennifer Caudle, DO, FACOFP
Dustin Le, MD, MHS
Niloo Nobakht, MD, FASN
Long-Term Efficacy and Safety Data in Ulcerative Colitis
Medical Industry FeatureLong-Term Efficacy and Safety Data in Ulcerative Colitis
Erica Cohen, MD
Ana’s Story – A Real Patient Living With Ulcerative Colitis
Medical Industry FeatureAna’s Story – A Real Patient Living With Ulcerative Colitis
Ana, A Real Patient Living With Ulcerative Colitis
Lukasz Kwapisz, MD
The Risk Equation: Combining uACR and eGFR for CV Prediction
Conversations in CV Risk AssessmentThe Risk Equation: Combining uACR and eGFR for CV Prediction
Matthew Sorrentino, MD
Ashish Verma, MBBS
Albuminuria: An Overlooked Red Flag in Cardiovascular Risk
Conversations in CV Risk AssessmentAlbuminuria: An Overlooked Red Flag in Cardiovascular Risk
Matthew Sorrentino, MD
Ashish Verma, MBBS
Hidden High Risk: When BP Control Isn’t Enough in Hypertension
Conversations in CV Risk AssessmentHidden High Risk: When BP Control Isn’t Enough in Hypertension
Gates B. Colbert, MD
Michael E. Hall, MD
Clyde W. Yancy, MD
- 06/26/2026
- 06/25/2026
- 06/24/2026
- 06/24/2026
- 06/24/2026
- 06/24/2026